Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer
Hongmiao Wang, Huixun Jia, Yang Gao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

High-Throughput Metabolic Pattern Screening Strategy for Early Colorectal and Gastric Cancers Based on Covalent Organic Frameworks-Assisted Laser Desorption/Ionization Mass Spectrometry
Chenjie Yang, Hailong Yu, Weihong Li, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 16, pp. 6264-6274
Closed Access | Times Cited: 9
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
Maxime W. Lafarge, Enric Domingo, Korsuk Sirinukunwattana, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents
Bangmin Yin, Yuping Cai, Teng Teng, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
High-Performance Metabolic Profiling of High-Risk Thyroid Nodules by ZrMOF Hybrids
Junyu Chen, Xi Yu, Yijiao Qu, et al.
ACS Nano (2024) Vol. 18, Iss. 32, pp. 21336-21346
Closed Access | Times Cited: 7
Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study
Zhihao Fang, Guohong Ren, Shouyu Ke, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Comprehensive MALDI mass spectrometry imaging of tumor regions post-neoadjuvant therapy
Hui Xu, Qian Zhang, Jie Yuan, et al.
Analytical and Bioanalytical Chemistry (2025)
Closed Access
Association of metabolic dysregulation with treatment response in rectal cancer patients undergoing chemoradiotherapy
Qiliang Peng, Yi Shen, Yingying Xu, et al.
BMC Medical Genomics (2025) Vol. 18, Iss. 1
Open Access
Multiomic traits reveal that critical irinotecan-related core regulator FSTL3 promotes CRC progression and affects ferroptosis
Cheng-Yi Huang, Bufu Tang, Wenjuan Chen, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Serum metabolomics to identify molecular subtypes and predict XELOX efficacy in colorectal cancer
Yijie Zhang, Lizhen Ye, Ying Qin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ginsenoside Rh4 alleviates gastrointestinal mucositis and enhances chemotherapy efficacy through modulating gut microbiota
Xue Bai, Jianjun Deng, Zhiguang Duan, et al.
Phytomedicine (2024) Vol. 128, pp. 155577-155577
Closed Access | Times Cited: 2
Metabolomic prediction of breast cancer treatment induced neurological and metabolic toxicities
Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 20, pp. 4654-4666
Closed Access | Times Cited: 2
OncoSexome: the landscape of sex-based differences in oncologic diseases
Xinyi Shen, Yintao Zhang, Jiamin Li, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1443-D1459
Open Access | Times Cited: 2
Validated Pretreatment Prediction Models for Response to Neoadjuvant Therapy in Patients with Rectal Cancer: A Systematic Review and Critical Appraisal
Max D. Tanaka, Barbara M. Geubels, Brechtje A. Grotenhuis, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3945-3945
Open Access | Times Cited: 6
LC–MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Qiliang Peng, Lili Jiang, Yi Shen, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
ZNF37A downregulation promotes TNFRSF6B expression and leads to therapeutic resistance to concurrent chemoradiotherapy in rectal cancer patients
Ying Huang, Jing Jin, Ningxin Ren, et al.
Translational Oncology (2024) Vol. 51, pp. 102203-102203
Open Access | Times Cited: 1
Multi-dataset study on neoadjuvant treatment-related prognostic model and molecular network mechanism of locally advanced rectal cancer
Wenzhao Su, Yong Wu, Chungen Xing
Research Square (Research Square) (2024)
Open Access
Metabolic features of adolescent major depressive disorder: A Comparative Study between Treatment-Resistant Depression and First-Episode Drug-Naive Depression
Xieyu Gan, Xuemei Li, Yuping Cai, et al.
Psychoneuroendocrinology (2024) Vol. 167, pp. 107086-107086
Closed Access
Identifying biomarkers for nasopharyngeal carcinoma diagnosis and chemoradiotherapy response using serum endogenous small molecules profiling
Zhangyao Xu, Hong Sun, Zhujian Wang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 251, pp. 116428-116428
Closed Access
ResNet-Vision Transformer based MRI-endoscopy fusion model for predicting treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A multicenter study
Junhao Zhang, Ruiqing Liu, Di Hao, et al.
Chinese Medical Journal (2024)
Open Access
Multiomic traits reveal critical irinotecan-related regulators in colorectal cancer, and irinotecan promotes ferroptosis in colorectal cancer by regulating FSTL3
Cheng-Yi Huang, Bufu Tang, Huiyin Lan, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top